Clinical Trial Update: Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

View source ↗

Summary

Pilot study evaluating lung shunting of Yttrium-90 microspheres using PET/CT in patients with advanced liver cancer and liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• Yttrium-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: University of Cincinnati | Conditions: Advanced Adult Primary Liver Cancer, Liver Metastases | Status: ACTIVE_NOT_RECRUITING